Form D · Pharmaceuticals
Groff North America, LLC
Red Lion, PA · CIK 0001985457
Offering snapshot reported Jul 14, 2023 · SEC filing
- Reported sold
- $13.1M Offering amount: $17.6M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jun 30, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2023 | Initial | $13,098,333 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486885
Source: Form D, filed Jul 14, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert A. Kinsley, Ii | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Redco Ave Suite A
Red Lion, PA, 17356
Red Lion, PA, 17356